← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Taligen Therapeutics, Inc.
Greenwood Village, CO
$1,018,424
Total funding
4
Grants
Funding over time
peak $555.7K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$1,018,424 · 4
By mechanism
R43$1,018,424 · 4
Investigators at Taligen Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Monoclonal antibody to Factor B as a Therapeutic in Asthma$287,641
R43 · FY2006 · AI
Monoclonal Antibody to Factor B as Therapeutic in Asthma$279,700
R43 · FY2005 · AI
Targeted Complement Inhibitors as Therapeutic Agents$178,740
R43 · FY2005 · DK
The Use of Complement Inhibitors as therapeutic agents in AMD$175,065
R43 · FY2006 · EY
A Novel Complement Inhibitor for Rheumatoid Arthritis$97,278
R43 · FY2005 · AR